COMPOSITIONS OF ADAGRASIB AND mTOR INHIBITORS AND METHODS OF TREATMENT THEREWITH
US20260097038A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name MIRATI THERAPEUTICS INC [US].
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
US20260097038A1 · Application publication visible